The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.
Pharmaceutical giant Pfizer is setting the price for a five-day treatment of Paxlovid at $1,390, but Americans can still access the pills at no cost -- for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.
